文献速递临床试验与 GCP

经机械滴管给药减轻舒芬太尼诱发咳嗽:一项前瞻性随机单盲试验

Application via mechanical dropper alleviates sufentanil-induced cough: a prospective, randomized, single-blinded trial.
PubMed 文献 · Trials · 2019-03-15

该前瞻性随机单盲试验纳入200例全麻患者,比较经T型连接器(C组)与机械滴管(M组)以1 ml·s-1速率给予0.3 μg·kg-1舒芬太尼后舒芬太尼诱发咳嗽(SIC)的发生率。M组SIC发生率显著低于C组(2% vs 21%,P=0.000),中度严重咳嗽发生率也显著低于C组(M组0例 vs C组11%,P=0.001),其他不良反应两组无统计学差异(P>0.05)。结论认为经机械滴管给药可显著减轻全凭静脉麻醉诱导期SIC。

要点

  • 经机械滴管给予舒芬太尼的SIC发生率为2%,显著低于T型连接器的21%(P=0.000)。
  • M组中度严重咳嗽发生率为0例,C组为11%,两组差异有统计学意义(P=0.001)。
  • 两组其他不良反应(低血压、高血压、心动过缓、心动过速、低氧血症、呕吐、误吸)发生率无统计学差异(P>0.05)。

核心结论

  • 经机械滴管给予舒芬太尼可显著减轻全凭静脉全麻诱导期舒芬太尼诱发咳嗽(SIC)的发生,该方法简单、安全、可靠,具有广泛的临床应用前景。

研究设计与样本

  • 前瞻性、随机、单盲试验,纳入200例接受全身麻醉的患者。
  • 患者以0.3 μg·kg-1剂量、1 ml·s-1速率经T型连接器(C组)或机械滴管(M组)给予舒芬太尼。
  • 主要结局为SIC发生率,次要结局为SIC严重程度及其他不良反应。
  • 咳嗽严重程度分级:无(0)、轻度(1-2)、中度(3-5)、重度(>5)。
  • 于舒芬太尼注射开始后5 min内评估SIC发生率。

主要发现

  • M组SIC发生率显著低于C组(2% vs 21%,P=0.000)。
  • M组中度严重咳嗽发生率为0例,C组为11%,两组差异有统计学意义(P=0.001)。
  • 两组其他不良反应(低血压、高血压、心动过缓、心动过速、低氧血症、呕吐、误吸)发生率无统计学差异(P>0.05)。

关键数值与推荐

  • 舒芬太尼给药强度为0.3 μg·kg-1,给药速率为1 ml·s-1。
  • SIC发生率:M组2% vs C组21%(P=0.000)。
  • 中度严重咳嗽发生率:M组0例 vs C组11%(P=0.001)。

临床怎么用

  • 作者认为经机械滴管给予舒芬太尼可显著减轻全凭静脉全麻诱导期SIC,该方法简单、安全、可靠,具有广泛的临床应用前景。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It was reported that prolonging the injection time or diluting administration can reduce the incidence of opioid-induced cough. However, the incidence of sufentanil-induced cough (SIC) via a standardized infusion rate is unclear. A mechanical dropper is an infusion filtering device commonly used for intravenous degassing; it can also be used to administer special drugs due to its temporary storage and dilution effect. This study assesses the effectiveness of administration via mechanical dropper on SIC. METHODS: Two hundred patients undergoing general anesthesia were enrolled. Patients received sufentanil at a strength of 0.3 μg·kg- 1 either via T-connector (group C) or by mechanical dropper (group M) at 1 ml·s- 1. Cough severity was graded as none (0), mild (1-2), moderate (3-5), or severe (> 5), and the incidence of SIC was evaluated for 5 min after the start of sufentanil injection. Other adverse reactions such as hypotension, hypertension, bradycardia, tachycardia, hypoxemia, vomiting, and aspiration during the induction period of general anesthesia were also observed. The primary outcome was the incidence of SIC. The secondary outcomes were the severity of SIC and other adverse reactions. RESULTS: The incidence of SIC in group M was significantly lower than that in group C (2% versus 21%, P = 0.000), and the prevalence of moderately severe coughing was also statistically different (none in group M versus 11% in group C, P = 0.001). However, there were no statistical differences in the incidence of other adverse reactions between two groups (P > 0.05). CONCLUSION: Sufentanil application via mechanical dropper can significantly alleviate the occurrence of SIC during the induction phase of total intravenous general anesthesia. This method is simple, safe, and reliable, and has wide prospective application for clinical use. TRIAL REGISTRATION: Chinese Clinical Trial Register, ChiCTR-IOR-17011561 . Registered on 3 June 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Liu M, Li Z, Wang S, et al. Application via mechanical dropper alleviates sufentanil-induced cough: a prospective, randomized, single-blinded trial. Trials. 2019. PMID: 30876430. doi:10.1186/s13063-019-3274-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。